Tag: Myasthenia Gravis Treatment Market Growth
Myasthenia Gravis Treatment Market Overview by Industry Chain Information, Upstream Raw Materials & Downstream Industry
The main cause of this increase is a higher disease incidence in the elderly, which is brought on by advances in diagnosis, treatment, and population longevity.
0
0
0
17 Mar, 07:14 AM
Myasthenia Gravis Treatment Market Demand by Top Market Players Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporation, Teva Pharmaceutical Industries Ltd.
The global myasthenia gravis treatment market was valued at around USD 1,011.1 million in 2017 and is expected to grow at a CAGR of 12.1% during the forecast period
0
0
0
1 Feb, 05:30 AM
